心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 CCS/CHFS立场声明：心脏淀粉样变性的评估和管理

2020-03-02 加拿大心血管学会 Can J Cardiol. 2020 Mar;36(3):322-334.

心脏淀粉样变性

2020年3月，加拿大心血管学会(CCS)联合加拿大心衰学会(CHFS)共同发布了心脏淀粉样变性的评估和管理声明，本文主要针对心脏淀粉样变性的评估和管理提供指导建议，内容涉及心衰以及其他心血管并发症的

中文标题：

2020 CCS/CHFS立场声明：心脏淀粉样变性的评估和管理

英文标题：

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.

发布机构：

加拿大心血管学会

发布日期：

2020-03-02

简要介绍：

2020年3月，加拿大心血管学会(CCS)联合加拿大心衰学会(CHFS)共同发布了心脏淀粉样变性的评估和管理声明，本文主要针对心脏淀粉样变性的评估和管理提供指导建议，内容涉及心衰以及其他心血管并发症的症状管理，危险分层，随访监测等。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=594f81c0018e9989, title=2020 CCS/CHFS立场声明：心脏淀粉样变性的评估和管理, enTitle=Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis., guiderFrom=Can J Cardiol. 2020 Mar;36(3):322-334., authorId=0, author=, summary=2020年3月，加拿大心血管学会(CCS)联合加拿大心衰学会(CHFS)共同发布了心脏淀粉样变性的评估和管理声明，本文主要针对心脏淀粉样变性的评估和管理提供指导建议，内容涉及心衰以及其他心血管并发症的, cover=https://img.medsci.cn/2020318/1584515513387_2020535.jpg, journalId=0, articlesId=null, associationId=263, associationName=加拿大心血管学会, associationIntro=加拿大心血管学会(CCS)通过传播研究结果和最佳治疗，促进心血管健康。《加拿大心脏病学期刊》（The Canadian Journal of Cardiology,CJC）是加拿大心血管学会(Canadian Cardiovascular Society,CCS)的官方期刊。本刊面向国际，发布心脏病学与心血管病科学新知识，是加拿大心血管学研究成果与加拿大心血管学会指导方针的主要发布场所。本刊发表与心血管医学相关的临床与基础研究的原创报告、社论、评审文章、案例报告，以及关于保健结果、政策研究、道德伦理、医学历史与医学政策问题的论文。, copyright=0, guiderPublishedTime=Mon Mar 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月，加拿大心血管学会(CCS)联合加拿大心衰学会(CHFS)共同发布了心脏淀粉样变性的评估和管理声明，本文主要针对心脏淀粉样变性的评估和管理提供指导建议，内容涉及心衰以及其他心血管并发症的症状管理，危险分层，随访监测等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=53139, tagName=心脏淀粉样变性)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=465, guiderKeyword=心脏, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2008, appHits=125, showAppHits=10, pcHits=623, showPcHits=1918, likes=0, shares=4, comments=4, approvalStatus=1, publishedTime=Wed Mar 18 16:22:08 CST 2020, publishedTimeString=2020-03-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 18 15:11:55 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 09:34:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=907951, encodeId=4f7f90e95124, content=感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:55:59 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901501, encodeId=8394901501a6, content=非常好，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Mon Nov 23 17:20:21 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889570, encodeId=fab08895e098, content=谢谢，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3f01326278, createdName=704078480, createdTime=Thu Oct 01 12:01:52 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-12-14 ms7000001209868210

    感谢!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=907951, encodeId=4f7f90e95124, content=感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:55:59 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901501, encodeId=8394901501a6, content=非常好，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Mon Nov 23 17:20:21 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889570, encodeId=fab08895e098, content=谢谢，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3f01326278, createdName=704078480, createdTime=Thu Oct 01 12:01:52 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-11-23 wxt0426

    非常好，谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=907951, encodeId=4f7f90e95124, content=感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb625438935, createdName=ms7000001209868210, createdTime=Mon Dec 14 20:55:59 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901501, encodeId=8394901501a6, content=非常好，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Mon Nov 23 17:20:21 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889570, encodeId=fab08895e098, content=谢谢，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3f01326278, createdName=704078480, createdTime=Thu Oct 01 12:01:52 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-10-01 704078480

    谢谢，谢谢

    0

拓展阅读

2014 ESC立场声明：心脏填塞紧急管理的分类策略

欧洲心脏病学会(ESC,European Society of Cardiology) · 2014-07-07

2014 IC-FoCUS 国际聚焦心脏超声循征建议

暂未更新 · 2014-07-31

2015 韩国适当应用心脏CT检查指南

韩国放射学会(KSR,Korean Society of Radiology) · 2015-02-27

2015 ACP建议：应用心电图、超声心动图或心肌灌注成像进行心脏检查

美国医师协会(ACP,American College of Physicians) · 2015-03-17

2016 CCS指南：接受非心脏手术患者围术期心脏风险评估和管理

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2016-10-01

2014 ASE指南：心脏超声检查对比心脏超声造影检查

美国超声心动图学会(ASE,American Society of Echocardiography) · 2014-08-01